IP Library Granted Patent US 10,451,630
Granted Patent B2
US 10,451,630 · App. 15/965,577 · Granted Oct 22, 2019

Systems and methods for high throughput analysis of conformation in biological entities

Inventors: Joshua Salafsky (San Francisco, CA); Louis J. Dietz (Mountain View, CA); Ray Hebert (Florence, OR); Dar Bahatt (Foster City, CA)
Assignee: BIODESY, INC.
G01N33/6845B01L3/5085B01L3/502715G01N21/552G01N21/636G01N33/54366G01N33/54373B01L2300/0636B01L2300/0819G02B5/04G02B5/045
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,451,630
App. No.
15/965,577
Granted
Oct 22, 2019
Kind
B2
Abstract

Methods, devices, and systems are disclosed for performing high throughput analysis of conformational change in biological molecules or other biological entities using surface-selective nonlinear optical detection techniques.

Claims (26)

1. A device comprising:

a) a substrate, the substrate comprising:

i) an M×N array of discrete regions on a surface of the substrate, wherein M is the number of rows of discrete regions and N is the number of columns of discrete regions in the array, and

ii) an R×S array of prisms integrated with the substrate and optically coupled to the discrete regions, wherein R is the number of rows of prisms and S is the number of columns of prisms in the array;

wherein each discrete region is located directly above a single prism of the array of prisms integrated with the substrate, and wherein R[≠]M and S=N, or R=M and S [≠]N.

2. The device of claim 1 , wherein each of the discrete regions is optically coupled with at least one input prism and at least one output prism, and wherein the input prism and the output prism are spatially distinct.

3. The device of claim 1 , wherein M=8 and N=12.

4. The device of claim 1 , wherein M=16 and N=24.

5. The device of claim 1 , wherein M=32 and N=48.

6. The device of claim 1 , wherein M is greater than 4 and N is greater than 4.

7. The device of claim 1 , wherein each discrete region comprises a supported lipid bilayer or is configured to facilitate the formation of a supported lipid bilayer.

8. The device of claim 1 , further comprising a well-forming component bonded to a top surface of the substrate in order to isolate each discrete region in a separate well.

9. The device of claim 1 , wherein each of the discrete regions comprises an area of up to about 100 mm 2 .

10. The device of claim 1 , wherein the substrate is composed of glass, fused-silica, or plastic.

11. A device comprising:

a) a substrate, the substrate comprising:

i) an M×N array of discrete regions on a surface of the substrate, wherein M is the number of rows of discrete regions and N is the number of columns of discrete regions in the array, and

ii) an R×S array of prisms integrated with the substrate and optically coupled to the discrete regions, wherein R is the number of rows of prisms and S is the number of columns of prisms in the array;

wherein each discrete region is located directly above a single prism of the array of prisms integrated with the substrate, and wherein each of the discrete regions is optically coupled with at least one input prism and at least one output prism that are not located directly beneath the discrete region.

12. The device of claim 11 , wherein M=8 and N=12.

13. The device of claim 11 , wherein M=16 and N=24.

14. The device of claim 11 , wherein M=32 and N=48.

15. The device of claim 11 , wherein M is greater than 4 and N is greater than 4.

16. The device of claim 11 , wherein each discrete region comprises a supported lipid bilayer or is configured to facilitate the formation of a supported lipid bilayer.

17. The device of claim 11 , further comprising a well-forming component bonded to a top surface of the substrate in order to isolate each discrete region in a separate well.

18. The device of claim 11 , wherein the substrate is composed of glass, fused-silica, or plastic.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 6, 2021
From: BLUELIGHT THERAPEUTICS, INC.
To: QUANTA THERAPEUTICS, INC.
Reel/Frame 057721/0206 →
CHANGE OF NAME Recorded Jun 24, 2020
From: BIODESY, INC.
To: BLUELIGHT THERAPEUTICS, INC.
Reel/Frame 053834/0130 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 21, 2018
From: SALAFSKY, JOSHUA S.; DIETZ, LOUIS J.; HEBERT, RAY; BAHATT, DAR
To: BIODESY, INC.
Reel/Frame 046645/0703 →
Continuity (3)
Continuation 14754465 · Jun 29, 2015
Provisional Application 62019285 · Jun 30, 2014
Related Publication 20180340940A1 · Nov 29, 2018